Modulators of BCL6 proteolysis and associated methods of use

This application pertains to the use of compounds, e.g., Compound A:, or a pharmaceutically acceptable salt thereof, for the treatment of various diseases or disorders, including, for example, diffuse large B-cell lymphoma (DLBCL) and angioimmunoblastic T-cell lymphoma.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SHERMAN, DAN, GOUGH, SHERYL MAXINE
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This application pertains to the use of compounds, e.g., Compound A:, or a pharmaceutically acceptable salt thereof, for the treatment of various diseases or disorders, including, for example, diffuse large B-cell lymphoma (DLBCL) and angioimmunoblastic T-cell lymphoma.